Medtronic EnVeo R (prosthesis of the aortal valve)

EnVeo R — the transkateterny prosthesis of the aortal valve of heart developed by Medtronic company. It is entered through a femoral artery, a subclavial artery or the ascending aorta. Transkateterny implantation of the aortal valve which is carried out through EnVeo R, considers one of the main methods of treatment of an aortal stenosis.

2016: 19 deaths

Main article: The rejected and dangerous products of Medtronic

In August, 2016 it became known of death of 19 people as a result of implantation of a transkateterny prosthesis of the aortal valve of heart of EnVeo R. The producer blames for it doctors.

According to sent the edition Minneapolis Star Tribune, Medtronic to the doctors working with EnVeo R, letters with notifications on a release of new installation instructions of a system. The company urges medical specialists "not apply force to carrying out" a catheter if it is entered hardly.

The device for treatment of heart troubles of Medtronic claimed 19 lives

Besides, the producer asked to draw special attention to patients who can have weak arteries. In case of the strong pressure upon a catheter, there can be an injury of blood vessels to implantation process.

By August, 2016 it is known of 39 cases when at patients to whom transactions through EnVeo R became arteries were injured. 19 patients died at the same time.

According to Minneapolis/St. Paul Business Journal, by August, 2016 the EnVeo R system was installed in organisms of 24 thousand people worldwide from which 7.3 thousand patients live in the USA. On a share of complications of EnVeo R is much more effective in comparison with surgeries on a heart valve, note in Medtronic.

The producer is not going to withdraw EnVeo R, as as he notes, the device is not defective, and the problem consists in installation process. In order that the help to doctors to learn it is correct to install the device, in the company created visual three-dimensional models of networks of blood vessels.^[1]

Notes